Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Maternal & Perinatal Health Institute (OMPHI) works alongside Nuffield Department of Women's & Reproductive Health - bringing together world experts to resolve priority maternal and perinatal health problems on a global scale.



The Oxford Maternal & Perinatal Health Institute was founded in 2009 under the aegis of Green Templeton College, University of Oxford. We engage medical researchers, social scientists and health management experts in some of the major issues affecting the health of mothers and newborn babies, particularly in resource-poor settings. We are running 4 large, global studies involving over 350 researchers from a wide range of countries. 




Intergrowth 21st

See INTERGROWTH-21st website here
See INTERGROWTH -21st overview and collaborators here


The INTERBIO-21st Study is an extension to the INTERGROWTH-21st Project. The study aims to improve the phenotypic characterisation of the fetal growth restriction/small for gestational age (FGR/SGA)  and preterm birth syndromes at molecular, biochemical and clinical levels so as to develop better strategies to correct the effects of an adverse intrauterine environment.

See INTERBIO-21st study website here
See INTERBIO-21st overview and collaborators here 



See INTERPRACTICE-21st website here
See INTERPRACTICE-21st overview and collaborators here


A study of more than 2,100 pregnant women across 18 countries worldwide has revealed that COVID-19 is associated with a higher risk of severe maternal and newborn complications than previously recognised.

Vaccine protects against pregnancy complications from COVID-19 Omicron variant Read more here 

Research uncovers high risk to pregnant women from COVID-19 Read more here

INTERCOVID-2022 Study launched to compare Covid-19 during pregnancy with pregnant women without the infection. Read more here

See INTERCOVID overview and collaborators here



The OMPHI International fellowship is awarded to fellows to develop specific skills relevant to the field of global Maternal & Perinatal Health. 

See Current Fellows and  Past Fellows 


our funders 

Our research focuses on fetal growth and nutrition and the effects of infection (e.g.malaria) in pregnancy; initiatives aimed at developing e-learning programmes in developing countries, and surveys of healthcare providers in resource-poor settings to identify barriers to implementing effective interventions in pregnancy. Our studies are funded by:

Bill & Melinda Gates Foundation

Family Larsson-Rosenquist Foundation  



MHTF is a project of the Women and Health Initiative at the Harvard T.H.Chan School of Public Health which works to create a strong, well-informed and integrated community with equitable access to high-quality technical evidence to eliminate preventable maternal mortality and morbidity worldwide. MHTF is led by Ana Langer, a physician specializing in pediatrics and neonatology and a reproductive health expert. 

OMPHI also works with The Geneva Foundation for Medical Education and Research on various joint initiatives. GFMER is a non-profit organisation established in 2002. It is supported by the Republic and Canton of Geneva, the Department of Social Affairs of the City of Geneva and other Swiss and international institutions. The Foundation works in close collaboration with the World Health Organization (WHO). GFMER is a WHO Collaborating Centre in Education and Research in Human Reproduction. The overall objectives of the Foundation are to furnish health education and research programmes that can be applied by developing countries, and countries in economic transition, and to establish collaboration between entities from the public and private sectors. See more 

Family Larsson-Rosenquist Foundation  is an independent, charitable organisation founded in an effort to fulfil the family’s vision of a world in which every child is granted an optimum start in life through the benefits of breast milk.



Our team

  • Michael Katz
    Michael Katz

    President of Oxford Maternal and Perinatal Health Institute (OMPHI).

  • Stephen Kennedy
    Stephen Kennedy

    Professor of Reproductive Medicine and Director of the Oxford Maternal and Perinatal Health Institute (OMPHI).

  • Aris Papageorghiou
    Aris Papageorghiou

    Professor of Fetal Medicine and Director of Research of the Oxford Maternal and Perinatal Health Institute (OMPHI).

  • Jimena Villar de Onis
    Jimena Villar de Onis

    Deputy Director for Programmes of the Oxford Maternal and Perinatal Health Institute (OMPHI).

  • Leila Cheikh Ismail
    Leila Cheikh Ismail

    Director of Field Studies (OMPHI), Project Leader (INTERGROWTH-21st)

Related research themes